Generating a Long-term Immune Response to Merkel Cell Carcinoma 2020 ASPIRE Award; 2022 ASPIRE II Award Paul Nghiem, MD, PhD, University of Washington Read More
Selectively Targeting Non-Proliferating Cancer Cells 2020 ASPIRE Award; 2022 ASPIRE II Award René Bernards, PhD, Netherlands Cancer Institute (Principal); Anthony Letai, MD, PhD, Dana-Farber Cancer Institute Read More
Targeting Chordoma Spinal Tumors Using Rational Drug Design 2020 Partnership with Chordoma Foundation David Drewry, PhD, University of North Carolina, Chapel Hill; Opher Gileadi, PhD, University of Oxford; Paul Workman, PhD, Institute for Cancer Research Read More
Using a High-Fiber Diet to Improve Melanoma Patients’ Response to Immunotherapy 2019 ASPIRE Award Jennifer McQuade, MD, MS (Principal); Jennifer Wargo, MD, MMSc; and Carrie Daniel-MacDougall, PhD, MPH, The University of Texas MD Anderson Cancer Center Read More
Using an FDA-Approved, Anti-Arthritis Drug to Improve Outcomes in Pancreatic Ductal Adenocarcinoma (PDAC) 2019 ASPIRE Award Cullen Taniguchi, MD, PhD (Principal); Anirban Maitra, MD; and Eugene Jon Koay, MD, The University of Texas MD Anderson Cancer Center Read More
Investigating a New Drug Target in Pancreatic Ductal Adenocarcinoma (PDAC) 2019 ASPIRE Award Lewis C. Cantley, PhD (Principal), Dana-Farber Cancer Institute, and Costas A. Lyssiotis, PhD, University of Michigan Read More
